211 related articles for article (PubMed ID: 25428913)
1. A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors.
Rahmatpanah FB; Jia Z; Chen X; Char JE; Men B; Franke AC; Jones FE; McClelland M; Mercola D
Oncotarget; 2015 Jan; 6(2):1286-301. PubMed ID: 25428913
[TBL] [Abstract][Full Text] [Related]
2. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
3. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
[TBL] [Abstract][Full Text] [Related]
4. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
6. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
Sirkisoon SR; Carpenter RL; Rimkus T; Doheny D; Zhu D; Aguayo NR; Xing F; Chan M; Ruiz J; Metheny-Barlow LJ; Strowd R; Lin J; Regua AT; Arrigo A; Anguelov M; Pasche B; Debinski W; Watabe K; Lo HW
Oncogene; 2020 Jan; 39(1):64-78. PubMed ID: 31462709
[TBL] [Abstract][Full Text] [Related]
7. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
Greber B; Lehrach H; Adjaye J
BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
[TBL] [Abstract][Full Text] [Related]
8. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on the expression of the stem cells related genes in hepatocellular carcinoma cell lines].
Zou C; Yuan FJ; Zhou WB; Huang L; Wang J; Zhang YS
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):599-602. PubMed ID: 19719918
[TBL] [Abstract][Full Text] [Related]
11. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues.
Wilson KS; Roberts H; Leek R; Harris AL; Geradts J
Am J Pathol; 2002 Oct; 161(4):1171-85. PubMed ID: 12368191
[TBL] [Abstract][Full Text] [Related]
13. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
[TBL] [Abstract][Full Text] [Related]
14. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
16. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
Peng L; Li FX; Shao WF; Xiong JB
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
[TBL] [Abstract][Full Text] [Related]
17. Comparisons between transcriptional regulation and RNA expression in human embryonic stem cell lines.
Player A; Wang Y; Bhattacharya B; Rao M; Puri RK; Kawasaki ES
Stem Cells Dev; 2006 Jun; 15(3):315-23. PubMed ID: 16846370
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen on the proportion of stem cells in the breast.
Simões BM; Piva M; Iriondo O; Comaills V; López-Ruiz JA; Zabalza I; Mieza JA; Acinas O; Vivanco MD
Breast Cancer Res Treat; 2011 Aug; 129(1):23-35. PubMed ID: 20859678
[TBL] [Abstract][Full Text] [Related]
19. Expansion of breast cancer stem cells with fibrous scaffolds.
Feng S; Duan X; Lo PK; Liu S; Liu X; Chen H; Wang Q
Integr Biol (Camb); 2013 May; 5(5):768-77. PubMed ID: 23529778
[TBL] [Abstract][Full Text] [Related]
20. HER2 regulatory control of angiopoietin-2 in breast cancer.
Carter WB; Ward MD
Surgery; 2000 Aug; 128(2):153-8. PubMed ID: 10922985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
